FDA Clearance Tracker · P040002-S002
POWERLINK SYSTEM
Last checked: Nov 20, 2026Latest source record: Feb 8, 2006 (this decision)Source: openFDAMethods & limitations
Decided
Feb 8, 2006
Approved
Time to decision
90 days
Received Nov 10, 2005. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P040002-S002
- Device name
- POWERLINK SYSTEM
- Applicant
- Endologix, LLC
- Applicant location
- Irvine, CA
- Received
- Nov 10, 2005
- Decided
- Feb 8, 2006
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P040002
Device type
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A MANUFACTURING SITE IN IRVINE, CALIFORNIA.
Source documents
Other decisions for Endologix, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- DETOUR SystemBreakthroughPMA
P220021 · Decided Jun 7, 2023 · 239 days after receipt
Device type: Stent graft, bypass, superficial femoral artery (QWM) · Cardiology
- Alto Abdominal Stent Graft SystemPMA supplement
P120006-S031 · Decided Mar 13, 2020 · 366 days after receipt · Panel Track
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.